← SynDRA
AMUVATINIB
SynDRA canonical compound SYN0030052 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PDGFRA |
|---|
| Mechanism of action | RET tyrosine kinase inhibitor |
|---|
All known targets
- KIT
- PDGFRA
- FLT3
- MET
- AXL
- MST1R
- RAD51
- RET
Mechanisms of action (all sources)
- KIT INHIBITOR
- FLT3 INHIBITOR
- PDGFR inhibitor
- RAD51 INHIBITOR
- RET tyrosine kinase inhibitor
- Tyrosine-protein kinase receptor FLT3 inhibitor
- Stem cell growth factor receptor inhibitor
- MET INHIBITOR
- Hepatocyte growth factor receptor inhibitor
- PDGFRA INHIBITOR
- Platelet-derived growth factor receptor alpha inhibitor
- PDGFR tyrosine kinase receptor inhibitor
Cross-references
Synonyms
- HPK-56
- HPK56
- MP-470
- MP470
- MP 470
- Amuvatinib (MP-470)
- UNII-SO9S6QZB4R
- Amuvatinib(MP470)
- N-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(benzofuro[3,2-d]pyrimidin-4-yl)piperazine-1-carbothioamide
- SO9S6QZB4R
- HPK 56
- N-(Benzo[d][1,3]dioxol-5-ylmethyl)-4-(benzofuro-[3,2-d]pyrimidin-4-yl)piperazine-1-carbothioamide
- N-(1,3-benzodioxol-5-ylmethyl)-4-([1]benzofuro[3,2-d]pyrimidin-4-yl)piperazine-1-carbothioamide
- Amuvatinib [USAN:INN]
- Amuvatinib (MP-470, HPK 56)
- PubChem22479
- Amuvatinib (USAN/INN)
- amuvatinibum
- RefChem:557931
- DTXCID50156667
- Receptor Tyrosine Kinase Inhibitor MP470
- MFCD16038298
- Amuvatinib [USAN]
- AMUVATINIB [INN]
- Amuvatinib (MP-470)?
- AMUVATINIB [WHO-DD]
- SCHEMBL93976
- MLS006010954
- GTPL7932
- orb1305369
- SCHEMBL29351463
- SCHEMBL29431554
- CHEBI:91389
- EX-A236
- FOFDIMHVKGYHRU-UHFFFAOYSA-N
- GLXC-06451
- HMS3244A11
- HMS3244A12
Look up AMUVATINIB in the interactive SynDRA portal →